Literature DB >> 23736957

[Early detection of colorectal cancer: role of endoscopy and imaging].

F T Kolligs1, A Graser.   

Abstract

Colorectal cancer is one of the leading causes of cancer-related morbidity and mortality. Colorectal cancer commonly develops slowly via adenomatous polyps, a process usually requiring ≥ 10 years. This allows for early detection. Endoscopic polypectomy and surgery of early disease can reduce the incidence and mortality of colorectal cancer. Both hemoccult testing and colonoscopy are the most widely used tests for colorectal cancer screening; however, colonoscopy has the highest sensitivity for colorectal neoplasia. Sigmoidoscopy is not commonly used for screening in Germany. Colon contrast enema is no longer recommended for screening. As colonoscopy serves as a diagnostic and therapeutic tool and is the reference method in hemoccult and sigmoidoscopy studies, it is viewed as the gold standard for the diagnosis of colonic disease. New methods including capsule colonoscopy and virtual colonoscopy have great potential but are currently not recommended for early detection of colonic neoplasia.

Entities:  

Mesh:

Year:  2013        PMID: 23736957     DOI: 10.1007/s00108-012-3237-9

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  28 in total

1.  Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults.

Authors:  Perry J Pickhardt; J Richard Choi; Inku Hwang; James A Butler; Michael L Puckett; Hans A Hildebrandt; Roy K Wong; Pamela A Nugent; Pauline A Mysliwiec; William R Schindler
Journal:  N Engl J Med       Date:  2003-12-01       Impact factor: 91.245

Review 2.  Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update.

Authors:  Paul Hewitson; Paul Glasziou; Eila Watson; Bernie Towler; Les Irwig
Journal:  Am J Gastroenterol       Date:  2008-05-13       Impact factor: 10.864

3.  Second-generation colon capsule endoscopy compared with colonoscopy.

Authors:  Cristiano Spada; Cesare Hassan; Miguel Munoz-Navas; Horst Neuhaus; Jacques Deviere; Paul Fockens; Emmanuel Coron; Gerard Gay; Ervin Toth; Maria Elena Riccioni; Cristina Carretero; Jean P Charton; Andrè Van Gossum; Carolien A Wientjes; Sylvie Sacher-Huvelin; Michel Delvaux; Artur Nemeth; Lucio Petruzziello; Cesar Prieto de Frias; Rupert Mayershofer; Leila Amininejad; Leila Aminejab; Evelien Dekker; Jean-Paul Galmiche; Muriel Frederic; Gabriele Wurm Johansson; Paola Cesaro; Guido Costamagna
Journal:  Gastrointest Endosc       Date:  2011-05-20       Impact factor: 9.427

4.  Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial.

Authors:  Esther M Stoop; Margriet C de Haan; Thomas R de Wijkerslooth; Patrick M Bossuyt; Marjolein van Ballegooijen; C Yung Nio; Marc J van de Vijver; Katharina Biermann; Maarten Thomeer; Monique E van Leerdam; Paul Fockens; Jaap Stoker; Ernst J Kuipers; Evelien Dekker
Journal:  Lancet Oncol       Date:  2011-11-15       Impact factor: 41.316

5.  CT colonography in senior versus nonsenior patients: extracolonic findings, recommendations for additional imaging, and polyp prevalence.

Authors:  Michael Macari; Gregory Nevsky; John Bonavita; Danny C Kim; Alec J Megibow; James S Babb
Journal:  Radiology       Date:  2011-04-05       Impact factor: 11.105

6.  Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals.

Authors:  David A Lieberman; Sheila Prindiville; David G Weiss; Walter Willett
Journal:  JAMA       Date:  2003-12-10       Impact factor: 56.272

7.  Accuracy of CT colonography for detection of large adenomas and cancers.

Authors:  C Daniel Johnson; Mei-Hsiu Chen; Alicia Y Toledano; Jay P Heiken; Abraham Dachman; Mark D Kuo; Christine O Menias; Betina Siewert; Jugesh I Cheema; Richard G Obregon; Jeff L Fidler; Peter Zimmerman; Karen M Horton; Kevin Coakley; Revathy B Iyer; Amy K Hara; Robert A Halvorsen; Giovanna Casola; Judy Yee; Benjamin A Herman; Lawrence J Burgart; Paul J Limburg
Journal:  N Engl J Med       Date:  2008-09-18       Impact factor: 91.245

8.  Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup.

Authors:  S J Winawer; A G Zauber; M N Ho; M J O'Brien; L S Gottlieb; S S Sternberg; J D Waye; M Schapiro; J H Bond; J F Panish
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245

9.  Computed tomographic colonography versus colonoscopy for investigation of patients with symptoms suggestive of colorectal cancer (SIGGAR): a multicentre randomised trial.

Authors:  Wendy Atkin; Edward Dadswell; Kate Wooldrage; Ines Kralj-Hans; Christian von Wagner; Rob Edwards; Guiqing Yao; Clive Kay; David Burling; Omar Faiz; Julian Teare; Richard J Lilford; Dion Morton; Jane Wardle; Steve Halligan
Journal:  Lancet       Date:  2013-02-14       Impact factor: 79.321

10.  Computed tomographic colonography versus barium enema for diagnosis of colorectal cancer or large polyps in symptomatic patients (SIGGAR): a multicentre randomised trial.

Authors:  Steve Halligan; Kate Wooldrage; Edward Dadswell; Ines Kralj-Hans; Christian von Wagner; Rob Edwards; Guiqing Yao; Clive Kay; David Burling; Omar Faiz; Julian Teare; Richard J Lilford; Dion Morton; Jane Wardle; Wendy Atkin
Journal:  Lancet       Date:  2013-02-14       Impact factor: 79.321

View more
  2 in total

1.  OPCML is frequently methylated in human colorectal cancer and its restored expression reverses EMT via downregulation of smad signaling.

Authors:  Chunhong Li; Liping Tang; Lijuan Zhao; Lili Li; Qian Xiao; Xinrong Luo; Weiyan Peng; Guosheng Ren; Qian Tao; Tingxiu Xiang
Journal:  Am J Cancer Res       Date:  2015-04-15       Impact factor: 6.166

2.  Quantitative diagnosis of colorectal polyps by spectral domain optical coherence tomography.

Authors:  Chen Wang; Qinqin Zhang; Xiaojing Wu; Tao Tang; Hong Liu; S W Zhu; Bruce Z Gao; X-C Yuan
Journal:  Biomed Res Int       Date:  2014-04-09       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.